AUTHOR=Yoest Jennifer M. , Shirai Cara Lunn , Duncavage Eric J. TITLE=Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia JOURNAL=Frontiers in Cell and Developmental Biology VOLUME=Volume 8 - 2020 YEAR=2020 URL=https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2020.00249 DOI=10.3389/fcell.2020.00249 ISSN=2296-634X ABSTRACT=Next generation sequencing (NGS) methods have allowed for unprecedented genomic characterization of acute myeloid leukemia (AML) over the last several years. Further advances in NGS based methods including error correction using unique molecular identifiers (UMIs) have more recently enabled the use of NGS-based measurable residual disease (MRD) detection. This review focuses on the use of NGS-based MRD detection in AML, including basic methodologies and clinical applications.